Clinical Trials Browser

Phase 1/2 × INDUSTRY × GATA2 Deficiency × Clear all

NCT05211570 2025-10-02

AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1/2 Recruiting

Other hematologic neoplasm

GATA2 Deficiency, Leukemia, Myeloid, Acute

NCT03018405 2019-09-19

THINK

Phase 1/2 Unknown

GATA2 Deficiency, Multiple Myeloma